News - GlaxoSmithKline


Current filters:


Popular Filters

201 to 225 of 450 results

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA


The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

Pfizer, GSK and Siemens join R&D consortium with A*STAR' on pharma production


US and UK pharma giants Pfizer (NYSE: PFE) and GlaxoSmithKline's (LSE: GSK) units Pfizer Asia Pacific…


Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site


UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

Global asthma market to reach 159 million lifetime cases by 2022


Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.…

GlaxoSmithKlineGlobalMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySeretideSingulair

Majority vote from FDA advisory panel to ease restrictions on GSK's Avandia


A joint advisory committee to the US Food and Drug Administration (FDA) voted to continue to make UK…

AvandiaDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Aqua Pharma acquires Verdeso Foam from GSK


West Chester-based, USA, Aqua Pharmaceuticals says it has acquired the US rights to, and re-launch of,…

Aqua PharmaceuticalsDermatologicalsGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVerdeso

GlaxoSmithKline's Tykerb/Tyverb and chemotherapy combo fails in gastric cancer


UK pharma giant GlaxoSmithKline (LSE: GSK) says that its study of Tykerb/Tyverb (lapatinib) in combination…


Research briefs: Lilly's Forteo; Genmab/GSK's Arzerra; AstraZeneca's Symbicort


US drug major Eli Lilly (NYSE: LLY) has reported new data demonstrating that Forteo (teriparatide) significantly…

Anti-Arthritics/RheumaticsArzerraAstraZenecaEli LillyForteoGenmabGlaxoSmithKlineOncologyPharmaceuticalResearchRespiratory and PulmonarySymbicort

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

FDA approves two GSK melanoma drugs and bioMerieux companion diagnostic


The US Food and Drug Administration yesterday (May 29) approved two new oral drugs from UK pharma giant…

BioMerieuxdabrafenibGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlartrametinib

GlaxoSmithKline gets $200 million BARDA award to develop new antibiotics


UK pharma giant GlaxoSmithKline (LSE: GSK) and the Biomedical Advanced Research and Development Authority…

Antibiotics and Infectious diseasesFinancialGlaxoSmithKlinePharmaceuticalResearch

GlaxoSmithKline reveals new research on health care models in developing countries


UK pharma giant GlaxoSmithKline (LSE: GSK) and the International Center for Social Franchising (ICSF)…


FDA approves Theravance and GSK's Breo Ellipta to treat COPD


The US Food and Drug Administration on Friday (May 10) approved Breo Ellipta (fluticasone furoate, an…

BiotechnologyBreo ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySkyepharmaTheravance Biopharma

Merck & Co's Gardasil and GSK's Cervarix to be available to developing countries via UNICEF tender


A new record low price for human papillomavirus (HPV) vaccines will help ensure millions of girls in…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingRest of the World

J&J's daratumumab gets "Breakthrough" status; GSK's trametinib delayed by FDA


The US Food and Drug Administration has granted "Breakthrough Therapy Designation" for health care giant…

daratumumabGenmabGlaxoSmithKlineJanssenJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRegulationtrametinib

GlaxoSmithKline files for umeclidinium monotherapy approval in Europe


UK pharma giant GlaxoSmithKline (LSE: GSK) has submitted a regulatory application in the European Union…

BiotechnologyEuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravanceumeclidinium

GlaxoSmithKline posts 2% fall in 1st-qtr sales but beats estimates


UK pharma giant GlaxoSmithKline (LSE: GSK) posted first-quarter 2013 results, with turnover coming in…


GlaxoSmithKline and Avalon Ventures in first-of-its-kind program to fuel early-stage innovation


San Diego, USA-based Avalon Ventures has entered into a collaboration with UK pharma giant GlaxoSmithKline…

Avalon VenturesBiotechnologyFinancialGlaxoSmithKlineNorth AmericaResearch

GlaxoSmithKline and Theravance file for Japanese approval of Anoro Ellipta


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) today April 22) announced…

Anoro ElliptaAsia-PacificGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

UK's OFT accuses GlaxoSmithKline of "market abuse"


The UK's Office of Fair Trading (OFT) today (April 19) issued a Statement of Objections to certain pharmaceutical…

AlpharmaEuropeGenericsGlaxoSmithKlineLegalMarkets & MarketingNeurologicalNorton HealthcarePaxilPharmaceuticalPricingSeroxat

FDA advisory panel backs approval of COPD drug Breo Ellipta


Having earlier this week been presented with ambivalent briefing papers, the US Food and Drug Administration's…

Breo ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

201 to 225 of 450 results

Back to top